{"name": "Interface Biologics",
 "permalink": "interface-biologics",
 "crunchbase_url": "http://www.crunchbase.com/company/interface-biologics",
 "homepage_url": "http://www.interfacebiologics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "information@interfacebiologics.com",
 "phone_number": "(416) 673-8170",
 "description": "",
 "created_at": "Wed Jan 12 04:37:35 UTC 2011",
 "updated_at": "Fri Dec 09 05:27:08 UTC 2011",
 "overview": "\u003Cp\u003EInterface Biologics Inc. operates as a biomaterials company. The company develops and markets polymer technologies that are programmed at the nano level for the combination medical device marketplace. It improves the biocompatibility of existing medical implants and blood-contacting devices. Interface Biologics provides lead product applications, such as vascular access catheters, drug eluting stents, and peritoneal dialysis catheters. The company was founded in 2001 and is headquartered in Toronto, Canada.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       34],
      "assets/images/resized/0011/6928/116928v1-max-150x150.png"],
     [[250,
       57],
      "assets/images/resized/0011/6928/116928v1-max-250x250.png"],
     [[334,
       77],
      "assets/images/resized/0011/6928/116928v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$8M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020110111e71b0002u\u0026r=Rss\u0026s=DJFVLS",
    "source_description": "Interface Biologics Completes $7M Series B Financing",
    "raised_amount": 7000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 1,
    "funded_day": 11,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2011/12/interface-biologics-receives-1m-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Interface Biologics Receives $1M in Financing",
    "raised_amount": 1000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 12,
    "funded_day": 8,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "MaRS Centre,South Tower",
    "address2": "101 College Street, Suite 300",
    "zip_code": "M5G 1L7",
    "city": "Toronto, ON",
    "state_code": null,
    "country_code": "CAN",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}